Company Filing History:
Years Active: 2023-2025
Title: Augusta Eleanor Broughton: Innovator in Immunology
Introduction
Augusta Eleanor Broughton is a notable inventor based in Fresno, CA. She has made significant contributions to the field of immunology, particularly through her work on antibodies that target the human CD96 receptor protein. With a total of 2 patents, her innovations are paving the way for new therapeutic approaches.
Latest Patents
Broughton's latest patents include the development of Anti-CD96 antibodies and methods of use thereof. These patents disclose binding proteins, such as antibodies and antigen-binding fragments, that specifically bind to the human CD96 receptor protein (hu-CD96). The antibodies are capable of decreasing, inhibiting, and fully blocking immune regulatory effects mediated by hu-CD96. Furthermore, the patents provide methods for using these antibodies to treat diseases and conditions that respond to the modulation of immune regulatory functions mediated by CD96 interactions.
Career Highlights
Augusta Broughton is currently employed at 23andMe, Inc., where she continues to advance her research in immunology. Her work is characterized by a commitment to developing innovative solutions that address complex health issues.
Collaborations
Broughton collaborates with talented individuals in her field, including Yu Chen and Chingwei Vivian Lee. These partnerships enhance her research and contribute to the success of her projects.
Conclusion
Augusta Eleanor Broughton is a pioneering inventor whose work on Anti-CD96 antibodies is making a significant impact in the field of immunology. Her contributions are essential for the development of new treatments that could improve patient outcomes.